Immune Disease Institute, Program in Cellular and Molecular Medicine, Children's Hospital Boston and Department of Pediatrics, Harvard Medical School, Boston, MA 02115, USA.
Breast Cancer Res. 2010;12(2):201. doi: 10.1186/bcr2484. Epub 2010 Mar 19.
MicroRNAs (miRNAs) are a major class of small endogenous RNA molecules that post-transcriptionally inhibit gene expression. Many miRNAs have been implicated in several human cancers, including breast cancer. Here we describe the association between altered miRNA signatures and breast cancer tumorigenesis and metastasis. The loss of several tumor suppressor miRNAs (miR-206, miR-17-5p, miR-125a, miR-125b, miR-200, let-7, miR-34 and miR-31) and the overexpression of certain oncogenic miRNAs (miR-21, miR-155, miR-10b, miR-373 and miR-520c) have been observed in many breast cancers. The gene networks orchestrated by these miRNAs are still largely unknown, although key targets have been identified that may contribute to the disease phenotype. Here we report how the observed perturbations in miRNA expression profiles may lead to disruption of key pathways involved in breast cancer.
微小 RNA(miRNAs)是一大类小型内源性 RNA 分子,可在后转录水平抑制基因表达。许多 miRNAs 与几种人类癌症有关,包括乳腺癌。在这里,我们描述了 miRNA 特征的改变与乳腺癌发生和转移之间的关联。在许多乳腺癌中观察到几种肿瘤抑制 miRNA(miR-206、miR-17-5p、miR-125a、miR-125b、miR-200、let-7、miR-34 和 miR-31)的缺失和某些致癌 miRNA(miR-21、miR-155、miR-10b、miR-373 和 miR-520c)的过表达。这些 miRNA 协调的基因网络在很大程度上仍然未知,尽管已经确定了关键靶点,这些靶点可能有助于疾病表型。在这里,我们报告了 miRNA 表达谱中观察到的扰动如何可能导致参与乳腺癌的关键途径中断。